IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Hold” from Analysts

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has earned a consensus recommendation of “Hold” from the nine analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Diamondback Energy (NASDAQ:FANG) Upgraded at Barclays
Next post First National Financial Co. (TSE:FN) Receives Consensus Recommendation of “Hold” from Analysts